| [1] |
罗国健,朱灿阳,杨承烨,等.儿童激素敏感型肾病综合征的药物治疗进展[J].海南医学,2025,36(6):899-907.
|
| [2] |
Vivarelli M, Gibson K, Sinha A, et al. Childhood nephrotic syndrome[J]. Lancet, 2023,402(10404):809-824.
|
| [3] |
匡金花,王莉,罗小丽.儿童难治性肾病综合征药物治疗的应用进展[J].成都医学院学报,2025,20(5):880-883.
|
| [4] |
Kallen R.History of childhood kidney disease and risk of adult End-Stage renal disease[J].N Engl J Med,2018,378(18):1750.
|
| [5] |
陈勇,王亚倩,宁小元,等.低剂量利妥昔单抗与环磷酰胺分别联合泼尼松治疗难治性肾病综合征患者的临床评价[J].中国药物应用与监测,2025,22(5):938-941.
|
| [6] |
Rovin BH, Adler SG, Barratt J, et al. Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases[J]. Kidney Int, 2021,100(4):753-779.
|
| [7] |
赵沛东,翟文生.中医药治疗儿童难治性肾病综合征疗效和安全性的Meta分析及中医证型分析[J].世界中西医结合杂志,2024,19(4):643-653.
|
| [8] |
高卓,李晓梅,隋丽娜.利妥昔单抗治疗儿童难治性肾病综合征的Meta分析[J].山东医药,2020,60(31):86-88.
|
| [9] |
樊宁宁,张齐武,张均,等.利妥昔单抗在难治性微小病变型肾病综合征中的疗效及分析[J].免疫学杂志,2021,37(2):153-158.
|
| [10] |
Ravani P, Rossi R, Bonanni A, et al. Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial[J]. J Am Soc Nephrol, 2015,26(9):2259-2266.
|
| [11] |
Chan EY, Yap DY, Colucci M, et al. Use of Rituximab in Childhood Idiopathic Nephrotic Syndrome[J]. Clin J Am Soc Nephrol, 2023,18(4):533-548.
|
| [12] |
Chan EY, Yu ELM, Angeletti A, et al. Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study[J]. J Am Soc Nephrol, 2022,33(6):1193-1207.
|
| [13] |
Deng J, Zhu L, Zhu X. Rituximab in pediatric refractory nephrotic syndrome: a systematic review and meta-analysis evaluating therapeutic efficacy and adverse event profiles[J]. Pediatr Nephrol, 2025.Epub ahead of print.
|
| [14] |
刘梦玲,丁樱,韩姗姗,等.基于“络以通为用”理论探讨儿童难治性肾病综合征的病机治法[J/OL].中医学报,1-6[2025-12-05]..
|
| [15] |
丁乐乐,韩姗姗,丁樱.中医药治疗儿童难治性肾病综合征研究进展[J].中国中西医结合杂志,2024,44(9):1141-1145.
|
| [16] |
郑健,艾斯,邱彩霞,等.小儿原发性肾病综合征中医证素特征及肾虚血瘀证的诊断研究[J].福建中医药大学学报,2014,24(4):1-4.
|
| [17] |
杨澜,庄翔莉,颜水平,等.郑健教授从“肾主虚”论治小儿原发性肾病综合征[J].中国中西医结合儿科学,2022,14(4):361-364.
|
| [18] |
颜水平,庄翔莉,艾斯,等.浅谈从“开鬼门,洁净府,去菀陈莝”论治小儿原发性肾病综合征[J].时珍国医国药,2021,32(4):931-932.
|
| [19] |
王菊霞,郑健.郑健教授分期论治小儿原发性肾病综合征经验[J].中医儿科杂志,2021,17(5):13-16.
|
| [20] |
李琼瑶,范雪琪,庄翔莉,等.郑健教授基于“肾虚血瘀”理论治疗小儿难治性肾病综合征经验撷要[J].中医临床研究,2025,17(11):98-104.
|
| [21] |
艾斯,郑健,邱彩霞,等.肾康灵对阿霉素肾病大鼠尿蛋白质组学的影响[J].中医杂志,2016,57(7):610-614.
|
| [22] |
郑健,姚勇.中西医结合儿童肾脏病学[M].北京:人民卫生出版社,2024:877.
|
| [23] |
免疫性肾小球疾病生物制剂治疗专家组.免疫性肾小球疾病生物制剂治疗中国专家共识[J].中华肾脏病杂志,2022,38(9):850-864.
|
| [24] |
He L, Mei H, Gu Y, et al. Combined impact of rituximab and target care on efficacy, quality of life, adverse reactions and recurrence rate in children with nephrotic syndrome: a randomized controlled trial[J]. BMC Pediatr, 2025,25(1):691.
|
| [25] |
Peng WT, Li XZ. Clinical study on low-dose rituximab maintenance therapy in children with primary nephrotic syndrome[J]. Zhongguo Dang Dai Er Ke Za Zhi, 2025,27(8):982-988.
|
| [26] |
勾雅琦,厉兆春.黄芪治疗肾病综合征的研究进展[J].中国民间疗法,2025,33(7):126-129.
|
| [27] |
高冲,刘璐,胡爱菊,等.活血化瘀中药的药理作用研究进展[J].药物评价研究,2013,36(1):64-68.
|
| [28] |
Angeletti A, Bruschi M, Kajana X, et al. Biologics in steroid resistant nephrotic syndrome in childhood: review and new hypothesis-driven treatment[J]. Front Immunol, 2023,14:1213203.
|
| [29] |
艾益颖,巫锐波,温子龙,等.儿童原发性肾病综合征经利妥昔单抗治疗后中医证型的演变规律及预后分析[J].临床肾脏病杂志,2025,25(6):457-464.
|
| [30] |
Xue HZ, Chen Y, Wang SD, et al. Radix astragali and its representative extracts for diabetic nephropathy: efficacy and molecular mechanism[J]. J Diabetes Res, 2024,2024:5216113.
|